Dow Jones Top Company Headlines at 9 AM ET: JPMorgan Forms New Team to Get In on the Boom in Private Markets | Halliburton ... While IPOs are expected to rise this year, the bank is betting on a ...

Adam Beshara, who has been a partner at Centerview Partners since 2012, will be one of five presidents at the firm when he ...

A court in Munich has granted a preliminary injunction that will prevent MSD from distributing the subcutaneous version of its cancer immunotherapy Keytruda in the German market. The verdict is the ...

The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

Hundreds of workers have worked since the Nov. 4 crash of UPS Flight 2976 in Louisville to clean the land and get the area ...

The new foot-and-mouth disease vaccine developed by researchers at Diamond Light Source is projected to deliver over $1.3 ...

Rising Demand for Safe, Sustainable Baby Apparel The global baby apparel market is experiencing steady growth, driven by ...

BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...

The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.

A tight job market has helped a Hawke’s Bay father go from jumping from job to job to finding a place where he can thrive. After a restructure didn’t go his way, Kole McGarvey spent the next three ...

Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion, following encouraging results from the company’s phase 2b trial of its lead ...